Urinary System pp 289-299 | Cite as

Experimental Renal Effects of Analgesics, Rat

  • Ranjit S. Nanra
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)


The gross appearance of the kidney is normal in most studies of experimental renal papillary necrosis. In experiments where analgesics have been fed to rats for prolonged periods of up to 72 weeks, macroscopic cortical scars may be noted.


Renal papillary necrosis Renal medullary necrosis Analgesic nephrotoxicity Nonsteroidal anti-inflammatory drug (NSAID) nephrotoxicity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abel JA (1971) Analgesic nephropathy - a review of the literature. Clin Pharmacol Ther 12:583–598PubMedGoogle Scholar
  2. Abrahams C, Levinson C (1970) Ultrastructure of the renal papilla in experimentally induced analgesic nephritis in rats. S Afr Med J 44:63–65PubMedGoogle Scholar
  3. Abrahams C, Rubenstein AH, Levin NW, Wunderlich U (1964) Experimentally induced analgesic nephritis in rat. Arch Pathol 78:222–230PubMedGoogle Scholar
  4. Axelsen RA (1975) The induction of renal papillary necrosis in Gunn rats by analgesics and analgesic mixtures. Br J Exp Pathol 56:92–97PubMedGoogle Scholar
  5. Axelsen RA (1976) Analgesic-induced renal papillary necrosis in the Gunn rat: the comparative nephrotoxicity of aspirin and phenacetin. J Pathol 120:145–150PubMedCrossRefGoogle Scholar
  6. Bach PH (1993) Experimental evidence and the biochemical basis for the role of analgesics in cancer. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 180–196Google Scholar
  7. Bach PH, Bridges JW (1985) Chemically induced renal papillary necrosis and upper urothelial carcinoma, parts 1 and 2. CRC Crit Rev Toxicol 15:217–439CrossRefGoogle Scholar
  8. Beswick EP, Schatzki PF (1960) Experimental renal papillary necrosis. Arch Pathol 69:733–740PubMedGoogle Scholar
  9. Björck S (1993) Paracetamol-induced renal tubular cell necrosis. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 174–179Google Scholar
  10. Burry A, Cross R, Axelsen R (1977) Analgesic nephropathy and the renal concentrating mechanism. Pathol Ann 12(2):1–13Google Scholar
  11. Carro-Ciampi G (1978) Phenacetin abuse: a review. Toxicology 10:311–339PubMedCrossRefGoogle Scholar
  12. Duggin GG (1980) Mechanisms in the development of analgesic nephropathy. Kidney Int 18:553–561PubMedCrossRefGoogle Scholar
  13. Edwards KDG, Curtis EA, Stoker LM (1971) One-day renal function testing in normal rats and in cases of experimentally-induced analgesic nephropathy, nephrocalcinosis and nephrotic syndrome. Nephron 8:235–245PubMedCrossRefGoogle Scholar
  14. Hanzlik PJ, Scott RW, Reycraft JL (1917) The salicylates. VIII. Salicyl oedema. Arch Intern Med 20:329–340CrossRefGoogle Scholar
  15. Hardy TL (1970) N-phenyl anthranilic acid: an agent for inducing and studying renal papillary necrosis in the rat. Br J Exp Pathol 51:348–355PubMedGoogle Scholar
  16. Haschek H (ed) (1973) Problems on phenacetin abuse. Facta, ViennaGoogle Scholar
  17. Isaka H, Yoshii H, Otsuji A, Koike M, Nagai Y, Koura M, Sugiyasu K, Kanabayashi T (1979) Tumours of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann 70:29–36PubMedGoogle Scholar
  18. Johansson SL (1991) Carcinogenicity of analgesics: longterm treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine, and paracetamol (acetaminophen). Int J Cancer 27:521–529CrossRefGoogle Scholar
  19. Kennedy A, Saluga PG (1970) Urinary cytology in experimental toxic renal injury. Ann Rheum Dis 29:546–552PubMedCrossRefGoogle Scholar
  20. Kimberly RP, Bowden RE, Keier HK, Plotz PH (1978) Reduction of renal function by newer nonsteroidal antiinflammatory drugs. Am J Med 64:804–807PubMedCrossRefGoogle Scholar
  21. Kincaid-Smith (ed) (1978) Analgesic nephropathy. Kidney Int 13:1–113Google Scholar
  22. Kleinknecht D (1993) Diseases of the kidney caused by non-steroidal anti-inflammatory drugs. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 160–173Google Scholar
  23. Markovic B (1971) Rescherches experimentales sur le role de la phenacetine dans la pathogenese des nephropathies interstielles chroniques. Arch Union Med Balk 9:591–598Google Scholar
  24. McMurtry RJ, Snodgrass WR, Mitchell JR (1978) Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol 46:87- 100PubMedCrossRefGoogle Scholar
  25. McCredie M (1993) Analgesics as human carcinogens - clinical and epidemiological evidence. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 197–210Google Scholar
  26. Mitchell JR, McMurtry RJ, Statham CN, Nelson SD (1977) Molecular basis for several drug-induced nephropathies. Am J Med 62:518–526PubMedCrossRefGoogle Scholar
  27. Molland EA (1978) Experimental renal papillary necrosis. Kidney Int 13:5–14PubMedCrossRefGoogle Scholar
  28. Mudge GH, Gemborys MW, Duggin GG (1978) Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathione. J Pharmacol Exp Ther 206:218–226PubMedGoogle Scholar
  29. Murray T, Goldberg M (1975) Analgesic abuse and renal disease. Annu Rev Med 26:537–550PubMedCrossRefGoogle Scholar
  30. Nanra RS (1976) Pathology, aetiology and pathogenesis of analgesic nephropathy. Aust NZ J Med 6 [SuppI1]:33–37Google Scholar
  31. Nanra RS (1980) Clinical and pathological aspects of analgesic nephropathy. Br J Clin Pharmacol 10 [Suppl 2]:359S-368SPubMedGoogle Scholar
  32. Nanra RS (1983) Renal effects of antityretic analgesics. Am J Med 75:70–81PubMedGoogle Scholar
  33. Nanra RS (1993a) Analgesic nephropathy in the 1990s – an Australian perspective. Kidney Int 44 [Suppl 42]:S86- S92Google Scholar
  34. Nanra RS (1993b) Analgesic-induced renal disease. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney, vol 2, 5th edn. Little Brown, Boston, pp 1104- 1129Google Scholar
  35. Nanra RS, Kincaid-Smith P (1970) Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br Med J 3:559–561PubMedCrossRefGoogle Scholar
  36. Nanra RS, Kincaid-Smith P (1972) Chronic effect of analgesic on the kidney. Prog Biochem Pharmacol 7:285–323PubMedGoogle Scholar
  37. Nanra RS, Kincaid-Smith P (1993) Experimental evidence for nephrotoxicity of analgesics. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 17–31Google Scholar
  38. Nanra RS, Chirawong P, Kincaid-Smith P (1973) Medullary ischaemia in experimental analgesic nephropathy - the pathogenesis of renal papillary necrosis. Aust NZ J Med 3:580–586CrossRefGoogle Scholar
  39. Nanra RS, Daniel V, Howard M (1980) Analgesic nephropathy induced by common proprietary mixtures. Med J Aust 1:486–487PubMedGoogle Scholar
  40. Nanra RS, Daniel V, Howard M, Gupta JW (1981) Physiological changes in experimental analgesic nephropathy. Proceedings of the VIlth International Congress on Nephrology, 1981, Athens (abstr DK 020)Google Scholar
  41. Nanra RS, Daniel V, Howard M, Murugesu R, White KH (1982) Uroepithehal hyperplasia and carcinoma in experimental analgesic nephropathy. Proceedings of the VllIth International Congress on Nephrology, 1982, Athens (abstr DK 021)Google Scholar
  42. Prescott LF (1966) The nephrotoxicity of analgesics. J Pharm Pharmacol 18:331–353PubMedCrossRefGoogle Scholar
  43. Prescott LF (1982) Analgesic nephropathy. A reassessment of the role of phenacetin and other analgesics. Drugs 23:75–149PubMedCrossRefGoogle Scholar
  44. Pugliese F, Cinotti GA (1993) Biochemistry and pharmacology of non-steroidal anti-inflammatory drugs and renal prostaglandins. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 133–146Google Scholar
  45. Rosner I (1974) Nephropathies experimentales aux analgesiques. Therapie 29:483–505PubMedGoogle Scholar
  46. Rosner I (1976) Experimental analgesic nephropathy. CRC Crit Rev Toxicol 4:331–352PubMedGoogle Scholar
  47. Sheehan HL, Davis JC (1959) Renal ischemia with good reflow. J Pathol Bacteriol 78:351–377PubMedCrossRefGoogle Scholar
  48. Shelley JH (1967) Phenacetin, through the looking glass. Clin Pharmacol Ther 8:427–471PubMedGoogle Scholar
  49. Steele TW, Edwards KDG (1970) Abnormalities of urinary concentrating, acidifying and sodium conserving abilities induced by excessive analgesic intake of rats. Aust Ann Med 19:412–413Google Scholar
  50. Williams GM, Weisburger JH (1986) Chemical carcinogens. In: Klassen CD, Amdur MO, Doull J (eds) Casarett and Doull’s toxicology: the basic science of poisons, 3rd edn. McMillan, New York, pp 99–173Google Scholar
  51. Winchester IF (1981) Georgetown University symposium of analgesics. Aspirin and acetaminophen. Arch Intern Med 141:273–406CrossRefGoogle Scholar
  52. Wiseman EH, Reinert H (1975) Anti-inflammatory drugs and renal papillary necrosis. Agents Actions 5:322–325PubMedCrossRefGoogle Scholar
  53. Wizgird JP, French SW, Coulson W (1965) Pathogenesis of serum-induced papillary necrosis. Arch Pathol 79:57- 64PubMedGoogle Scholar
  54. Zambraski EJ, Dunn MJ (1993) Effects of non-steroidal anti-inflammatory drugs on renal function. In: Stewart JH (ed) Analgesic and NSAID-induced kidney disease. Oxford University Press, New York, pp 147–159Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Ranjit S. Nanra

There are no affiliations available

Personalised recommendations